Gene expression profiling in rat liver treated with various hepatotoxic-compounds inducing coagulopathy

Journal of Toxicological Sciences

Volumn 34, Issue 3, 2009, Pages 281-293

  Hirode, Mitsuhiro ^a   Omura, Ko ^a   Kiyosawa, Naoki ^a   Uehara, Takeki ^a   Shimuzu, Toshinobu ^a   Ono, Atsushi ^a,b   Miyagishima, Toshikazu ^a   Nagao, Taku ^c   Ohno, Yasuo ^a,b   Urushidani, Tetsuro ^a,d  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c Food Safety Commission of Japan   (Japan)

^d DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Coagulopathy; Liver; Rat; Toxicogenomics

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; AMIODARONE; ASPARTATE AMINOTRANSFERASE; BENZBROMARONE; CLOFIBRATE; ETHIONINE; OMEPRAZOLE; OXIDOREDUCTASE; PIRINIXIC ACID; PROPYLTHIOURACIL; PROTEIN VKORC LIKE 1; PROTEIN VKORC1; THIOACETAMIDE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CHEMISTRY; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; GENE EXPRESSION PROFILING; LIPID METABOLISM; LIVER TOXICITY; MALE; NONHUMAN; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; RAT; TOXICOGENETICS; TRANSCRIPTOMICS;

RATTUS;

EID: 67649211924     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.281     Document Type: Article

References (33)

1. Amitrano, L., Guardascione, M.A., Brancaccio, V. and Balzano, A. (2002): Coagulation disorders in liver disease. Semin. Liver Dis., 22, 83-96.
2. Berndt, M.C., Shen, Y., Dopheide, S.M., Gardiner, E.E. and Andrews, R.K. (2001): The vascular biology of the glycoprotein Ib-IX-V complex. Thromb. Haemost., 86, 178-188.
3. Caldwell, S.H., Chang, C. and Macik, B.G. (2004): Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials. Hepatology, 39, 592-598. (Pubitemid 38337636)
4. Cattaneo, M., Chahil, A., Somers, D., Kinlough-Rathbone, R.L., Packham, M.A. and Mustard, J.F. (1983): Effect of aspirin and sodium salicylate on thrombosis, fibrinolysis, prothrombin time, and platelet survival in rabbits with indwelling aortic catheters. Blood, 61, 353-361. (Pubitemid 13137657)
5. Dennis, G.Jr., Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C. and Lempicki, R.A. (2003): DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol., 4, P3.
6. Fujii, T. (1997): Toxicological correlation between changes in blood biochemical parameters and liver histopathological findings. J. Toxicol. Sci., 22, 161-183.
7. Gervois, P., Vu-Dac, N., Kleemann, R., Kockx, M., Dubois, G., Lame, B., Kosykh, V., Fruchart, J.C., Kooistra, T. and Staels, B. (2001): Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J. Biol. Chem., 276, 33471-33477.
8. Gettins, P.G. (2002): Serpin structure, mechanism, and function. Chem. Rev., 102, 4751-4804.
9. Hirode, M., Ono, A., Miyagishima, T., Nagao, T., Ohno, Y. and Urushidani, T. (2008): Gene expression profiling in rat liver treated with compounds inducing phospholipidosis. Toxicol. AppI. Pharmacol., 229, 290-299.
10. Hirode, M., Horinouchi, A., Uehara, T., Ono, A., Miyagishima, T., Yamada, H., Nagao, T., Ohno, Y. and Urushidani, T. (2009): Gene expression profiling in rat liver treated with compounds inducing elevation of bilirubin. Hum. Exp. Toxicol. (in press).
11. Kalsheker, N., Morley, S. and Morgan, K. (2002): Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alphalantichymotrypsin. Biochem. Soc. Trans., 30, 93-98.
12. Kerr, R. (2003): New insights into haemostasis in liver failure. Blood. Coagul. Fibrinolysis, 14 Suppl 1, S43-45.
13. Kerr, R., Newsome, P., Germain, L., Thomson, E., Dawson, P., Stirling, D. and Ludlam, C.A. (2003): Effects of acute liver injury on blood coagulation. J. Thromb. Haemost., 1, 754-759.
14. Kiyosawa, N., Uehara, T., Gao, W., Omura, K., Hirode, M., Shimizu, T., Mizukawa, Y., Ono, A., Miyagishima, T., Nagao, T. and Urushidani, T. (2007): Identification of glutathione depletion- responsive genes using phorone-treated rat liver. J. Toxicol. Sci., 32,469-486.
15. Lipsky, J.J. and Gallego, M.O. (1988): Mechanism of thioamide antithyroid drug associated hypoprothrombinemia. Drug. Metabol. Drug. Interact., 6, 317-326.
16. Mackiewicz, A. and Kushner, I. (1990): Transforming growth factor beta 1 influences glycosylation of alpha 1-protease inhibitor in human hepatoma cell lines. Inflammation., 14,485-497.
17. Magielska-Zero, D., Bereta, J., Czuba-Pelech, B., Pajdak, W., Gauldie, J. and Koj, A. (1988): Inhibitory effect of human recombinant interferon gamma on synthesis of acute phase proteins in human hepatoma Hep G2 cells stimulated by leukocyte cytokines, TNF alpha and IFN-beta 2/BSF-2/IL-6. Biochem. Int., 17, 17-23.
18. Omura, K., Kiyosawa, N., Uehara, T., Hirode, M., Shimizu, T., Miyagishima, T., Ono, A., Nagao, T. and Urushidani, T. (2007): Gene expression profiling of rat liver treated with serum triglyceride-decreasing compounds. J. Toxicol. Sci., 32, 387-3 99.
19. Ozer, J., Ratner, M., Shaw, M., Bailey, W. and Schomaker, S. (2008): The current state of serum biomarkers of hepatotoxicity. Toxicology., 245, 194-205.
20. Peck-Radosavijevic, M. (2007): Review article: coagulation disorders in chronic liver disease. Aliment. Pharmacol. Ther., 26 Suppl 1, 21-28.
21. Savage, B., Shattil, S.J. and Ruggeri, Z.M. (1992): Modulation of platelet function through adhesion receptors. a dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J. Biol. Chem., 267, 11300-11306.
22. Selwyn, A.P. (2003): Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am. J. Cardiol., 91, 3H-11H.
23. Silverman, G.A., Bird, P.I., Carrell, R.W., Church, F.C., Coughlin, P.B., Gettins, P.O., Irving, J.A., Lomas, D.A., Luke, C.J., Moyer, R.W., Pemberton, P.A., Remold-O'Donnell, E., Salvesen, G.S., Travis, J. and Whisstock, J.C. (2001): The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem., 276, 33293-33296.
24. Takashima, K., Mizukawa, Y., Morishita, K., Okuyama, M., Kasahara, T., Toritsuka, N., Miyagishima, T., Nagao, T. and Urushidani, T. (2006): Effect of the difference in vehicles on gene expression in the rat liver - analysis of the control data in the Toxicogenomics Project Database. Life Sci., 78, 2787-2796.
25. Tamura, K., Ono, A., Miyagishima, T., Nagao, T. and Urushidani, T. (2006): Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators. J. Toxicol. Sci., 31, 471-490.
26. Uehara, T., Hirode, M., Ono, A., Kiyosawa, N., Omura, K., Shimizu, T., Mizukawa, Y., Miyagishima, T., Nagao, T. and Urushidani, T. (2008): A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology., 250, 15-26.
27. Urushidani, T. (2008): Prediction of Hepatotoxicity Based on the Toxicogenomics Database. In Hepatotoxicity: from Genomics to in vitro and in vivo Models. (Sahu, S.C. ed.), pp. 507-529, John Wiley & Sons, Chichester, West Sussex, England.
28. Vacca, J.P. (2000): New advances in the discovery of thrombin and factor Xa inhibitors. Curr. Opin. Chem. Biol., 4, 394-400.
29. van de Locht, A., Lamba, D., Bauer, M., Huber, R., Friedrich, T., Kröger, B., Hoffken, W. and Bode, W. (1995): Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J., 14, 5149-5157.
30. Wadelius, M., Chen, L.Y., Eriksson, N., Bumpstead, S., Ghori, J., Wadelius, C., Bentley, D., McGinnis, R. and Deloukas, P. (2007): Association of warfarin dose with genes involved in its action and metabolism. Hum. Genet., 121, 23-34.
31. Watson, S.P. (1999): Collagen receptor signaling in platelets and megakaryocytes. Thromb. Haemost., 82, 365-376.
32. Yin, T., Hanada, H., Miyashita, K., Kokubo, Y., Akaiwa, Y., Otsubo, R., Nagatsuka, K., Otsuki, T., Okayama, A., Minematsu K., Naritomi, H., Tomoike, H. and Miyata, T. (2008): No association between vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) and the variability of warfarin dose requirement in a Japanese patient population. Thromb. Res., 122, 179-184.
33. Yip, L. (2004): Salicylates. In Medical Toxicology (Dart, R.C. et al., ed.), pp. 739-749, Lippincott Williams & Wilkins, Philadelphia, PA, USA.